Hanson McClain Advisors »

Anika Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $103 11 9.45
2025-06-30 $126 12 10.58

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Usd Inv Grde Etf (USIG)
Nvidia Corporation Call Call Option (Principal) (NVDA)

View all positions for Hanson McClain Advisors

Top funds holding Anika Therapeutics

BlackRock
Trigran Investments
Caligan Partners
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
Capital Management Corporation
Boothbay Fund Management
Renaissance Technologies
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Envestnet Asset Management
Northern Trust
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics